Company intelligence / Profile preview

Navilluso Medical

Kaitaia/Auckland, Northland/Auckland, New Zealandfacebook.com ↗

Ownership: Private
Development stage: Other

Overview

Navilluso Medical has developed and deployed the iMOKO digital health programme to deliver primary healthcare services remotely to children and underserved communities in New Zealand. The company’s technology has been used in schools and rural areas to improve access to basic medical care. Clinical results focus on improved access and early intervention rather than traditional drug development outcomes.

Therapeutic areas: Other
Modalities: DeviceNon-pharmacological therapy (digital health platform)
Industry: Non-Academic Healthcare

Partnerships

Precision Driven Health consortiumNew Zealand Ministry of HealthAccident Compensation Corporation of NZ

Beyond the preview

Go deeper on Navilluso Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Navilluso Medical.

Explore the full profile